Welch, Stephen

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

Sangro, B., Chan, S. L., Kelley, R. K., Lau, G., Kudo, M., Sukeepaisarnjaroen, W., Yarchoan, M., De Toni, E. N., Furuse, J., Kang, Y. K., et al. (2024) · Annals of Oncology

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers

Cited by 365

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care

Miller, F. A., Hayeems, R. Z., Bytautas, J. P., Bedard, P. L., Ernst, S., Hirte, H., Hotte, S., Oza, A., Razak, A., Welch, S., et al. (2014) · European Journal of Human Genetics

BRCA gene mutations in cancerCancer Genomics and Diagnostics

Cited by 116

Is the Medical Oncology Workforce in Canada in Jeopardy? Findings from the Canadian Association of Medical Oncologists’ COVID-19 Impact Survey Series

Jones, L., Colwell, B., Hao, D., Welch, S., Campbell, A., & Gill, S. (2024) · Current Oncology

Healthcare professionals’ stress and burnoutHealthcare Systems and Challenges

Cited by 3